HENRY J FUCHS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HENRY J FUCHS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HENRY J FUCHS. HENRY J FUCHS is a EVP, Chief Medical Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a President, Worldwide R&D in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a President & CEO in Ardea Biosciences, Inc./DE ($IBPI) and a Director in GENOMIC HEALTH INC ($GHDX) and a in Mirati Therapeutics, Inc. ($MYG) and a Director in Mirati Therapeutics, Inc. ($MYG).
Address: 2483 E. BAYSHORE RD, SUITE 100 PALO ALTO 94303 CA
Companies in which HENRY J FUCHS is an Insider
Ardea Biosciences, Inc./DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of HENRY J FUCHS: President & CEO
Holdings: 0 shares
Latest Transaction: May 10 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOMARIN PHARMACEUTICAL INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of HENRY J FUCHS: President, Worldwide R&D, EVP, Chief Medical Officer
Holdings: 106,142 shares
Current Value: $9,437,085
Latest Transaction: Mar 23 2021
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of HENRY J FUCHS: Director
Holdings: 955 shares
Current Value: $26,253
Latest Transaction: Nov 14 2019
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mirati Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of HENRY J FUCHS:
Holdings: 3,475 shares
Latest Transaction: Jan 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of HENRY J FUCHS
Sentiment: All, IBPI, BMRN, GHDX, MYG
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 78.52 | 2,454 | 192,688 | 106,142 | 108.6 K to 106.1 K (-2.26 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | A | 78.39 | 37,710 | 2,956,087 | 37,710 | |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 77.21 | 2,259 | 174,417 | 108,596 | 110.9 K to 108.6 K (-2.04 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 78.39 | 7,460 | 584,789 | 110,855 | 118.3 K to 110.9 K (-6.31 %) |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Grant | A | 0.00 | 15,320 | 0 | 118,315 | 103 K to 118.3 K (+14.87 %) |
| Jan 20 2021 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Option Exercise | A | 214.47 | 2,155 | 462,183 | 2,155 | ||
| Jan 20 2021 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Grant | A | 0.00 | 1,475 | 0 | 3,475 | 2 K to 3.5 K (+73.75 %) |